Delivery Order SPE2DB20D3104-SPE2DB25FW0C6
- Not listed
- The Defense Logistics Agency awarded a $1,505.59 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, with an ultimate completion...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lantus SoloStar 100 Unit/ml insulin pens (3ml) with a ceiling value of $1,022.80. This is a firm fixed price delivery order with no set-aside designation, reflecting a competitive award to support federal medical procurement needs. The order is scheduled for completion by September 11, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $8,618.60 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This firm fixed-price, non-set-aside contract is scheduled for completion by September 10, 2025, with performance at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,227.36 to supply Lantus SoloStar 100 Unit/ML 3ML insulin pens. This non-competitive, firm fixed price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $1,379.08 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens (3mL format) on August 5, 2025, with completion scheduled for August 6, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a small-value pharmaceutical procurement supporting military and federal healthcare operations. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $1,227.36 delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin pens (3mL formulation). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 26, 2025, with performance to be executed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract valued at $2,110.44 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin pens (3mL). This competitively awarded, firm fixed-price delivery order was issued on August 8, 2025, with an ultimate completion date of August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a $1,317.48 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Lantus SoloStar 100 Unit/ML 3ML insulin pens. This firm fixed-price contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of July 24, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award falls under the company's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin pens (3mL) with a contract ceiling value of $1,923.70. This firm fixed-price delivery order, which is set to be completed by September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement without...
- The Defense Logistics Agency awarded a delivery order valued at $3,172.50 to AmerisourceBergen Drug Corp for Lantus SoloStar 100 Unit/mL insulin pens on September 9, 2025, with completion targeted for September 10, 2025. This competitive, non-set-aside award utilizes firm fixed pricing and represents a direct fulfillment of pharmaceutical supply needs for the Department of Defense. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FW0C6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin pens, with a ceiling value of $1,022.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a child contract, this delivery order draws from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company's extensive portfolio under its DLA IDC encompasses a wide range of pharmaceutical products, including diabetes medications, neurological treatments, pain management drugs, antibiotics, vaccines, and specialized medical supplies. This delivery order for Lantus insulin represents a routine procurement from that broader contract vehicle, supporting the Defense Health Agency and other government healthcare systems' pharmaceutical supply needs. The ultimate completion date for this delivery order is September 11, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/10/25 |